Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Change Healthcare’s Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Change Healthcare (NASDAQ:CHNG) earned $44.14 million, a 2.61% increase from the preceding quarter. Change Healthcare also posted a total of $867.86 million in sales, a 1.48% increase since Q4.

According to Benzinga Pro, during Q1, Change Healthcare (NASDAQ:CHNG) earned $44.14 million, a 2.61% increase from the preceding quarter. Change Healthcare also posted a total of $867.86 million in sales, a 1.48% increase since Q4. In Q4, Change Healthcare earned $43.02 million, and total sales reached $855.16 million.

What Is ROIC?

Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company’s ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q1, Change Healthcare posted an ROIC of 0.59%.

Keep in mind, while ROIC is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company’s ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q1, Change Healthcare posted an ROIC of 0.59%.

Keep in mind, while ROIC is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

For Change Healthcare, the positive return on invested capital ratio of 0.59% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Analyst Predictions

Change Healthcare reported Q1 earnings per share at $0.41/share, which did not meet analyst predictions of $0.44/share.

Total
0
Shares
Related Posts
Read More

Regenxbio: Q4 Earnings Insights

Regenxbio (NASDAQ:RGNX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Regenxbio beat estimated earnings by 41.61%, reporting an EPS of $6.67 versus an estimate of $4.71.

RGNX